Company attributes
Industry
Location
B2X
0
CEO
Founder
AngelList URL
Pitchbook URL
Legal Name
resTORbio, Inc.
Date Incorporated
2016
Number of Employees (Ranges)
11 – 50
Email Address
contact@restorbio.com0
recruiting@restorbio.com0
restorbiocom@gmail.com
ir@restorbio.com0
clinicaltrials@restorbio.com0
Phone Number
+18573155528
Number of Employees
18
Full Address
500 Boylston Street, 13th Floor Boston, MA 021160
Investors
Founded Date
2016
Total Funding Amount (USD)
105,000,000
Latest Funding Round Date
November 30, 2017
Competitors
Latest Funding Type
Patents Assigned (Count)
1
Wellfound ID
Country
Other attributes
Acquirer
Company Operating Status
Active
Latest Funding Round Amount (USD)
40,000,000
resTORbio is a biopharmaceutical company developing therapeutics for treating age-related diseases that is headquartered in Boston, Massachusetts and was founded in 2016 by Chen Schor and Joan Mannick.
Funding
Series A
On January 1, 2017 resTORbio completed their series A funding round with $25 million in funding from PureTech Health.
Series B
On November 30, 2017 resTORbio completed their series B funding rounds with $40 million in funding from OrbiMed (lead investor), Rock Springs Capital, Recharge Capital, Quan Capital, Nest.Bio Ventures, and Fidelity Management and Research Company.
Timeline
No Timeline data yet.
